JPMorgan Chase & Co. Raises Stock Holdings in Nature’s Sunshine Products, Inc. (NASDAQ:NATR)

JPMorgan Chase & Co. grew its stake in shares of Nature’s Sunshine Products, Inc. (NASDAQ:NATRFree Report) by 24.3% during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 34,633 shares of the company’s stock after acquiring an additional 6,769 shares during the quarter. JPMorgan Chase & Co. owned about 0.19% of Nature’s Sunshine Products worth $472,000 as of its most recent SEC filing.

A number of other large investors have also recently made changes to their positions in the stock. Wasatch Advisors LP grew its position in Nature’s Sunshine Products by 23.2% in the 3rd quarter. Wasatch Advisors LP now owns 696,184 shares of the company’s stock worth $9,482,000 after purchasing an additional 131,174 shares during the period. Barclays PLC boosted its stake in shares of Nature’s Sunshine Products by 51.8% in the 3rd quarter. Barclays PLC now owns 35,602 shares of the company’s stock worth $485,000 after buying an additional 12,152 shares during the last quarter. Franklin Resources Inc. grew its holdings in shares of Nature’s Sunshine Products by 4.3% in the third quarter. Franklin Resources Inc. now owns 20,744 shares of the company’s stock worth $270,000 after acquiring an additional 856 shares during the period. XTX Topco Ltd purchased a new stake in Nature’s Sunshine Products during the second quarter valued at $180,000. Finally, Dimensional Fund Advisors LP lifted its stake in shares of Nature’s Sunshine Products by 4.7% in the 2nd quarter. Dimensional Fund Advisors LP now owns 786,966 shares of the company’s stock worth $11,860,000 after purchasing an additional 34,996 shares during the period. 79.40% of the stock is currently owned by institutional investors.

Nature’s Sunshine Products Price Performance

Shares of NATR stock opened at $14.83 on Wednesday. Nature’s Sunshine Products, Inc. has a 1 year low of $10.81 and a 1 year high of $21.72. The firm has a fifty day moving average price of $15.23 and a 200-day moving average price of $14.48. The company has a market cap of $274.06 million, a price-to-earnings ratio of 16.85 and a beta of 0.96.

Nature’s Sunshine Products (NASDAQ:NATRGet Free Report) last posted its quarterly earnings data on Thursday, November 7th. The company reported $0.27 EPS for the quarter. The firm had revenue of $114.62 million for the quarter. Nature’s Sunshine Products had a return on equity of 11.08% and a net margin of 3.81%.

About Nature’s Sunshine Products

(Free Report)

Nature’s Sunshine Products, Inc, a natural health and wellness company, manufactures and sells nutritional and personal care products in Asia, Europe, North America, Latin America, and internationally. It offers general health products related to blood sugar support, bone health, cellular health, cognitive function, joint health, mood, sexual health, sleep, sports and energy, and vision.

Featured Stories

Want to see what other hedge funds are holding NATR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Nature’s Sunshine Products, Inc. (NASDAQ:NATRFree Report).

Institutional Ownership by Quarter for Nature's Sunshine Products (NASDAQ:NATR)

Receive News & Ratings for Nature's Sunshine Products Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nature's Sunshine Products and related companies with MarketBeat.com's FREE daily email newsletter.